{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:18:21Z","timestamp":1787170701692,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Chongqing, China","award":["[No. CSTB2023NSCQ-MSX020]"],"award-info":[{"award-number":["[No. CSTB2023NSCQ-MSX020]"]}]},{"name":"Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University","award":["Grant [2021] 24"],"award-info":[{"award-number":["Grant [2021] 24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03537-9","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T10:02:22Z","timestamp":1727517742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prediction of non-sentinel lymph node metastases in T1\u20132 sentinel lymph node-positive breast cancer patients undergoing mastectomy following neoadjuvant therapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaoxi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"1","key":"3537_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-med-051413-024741","volume":"66","author":"D Zardavas","year":"2015","unstructured":"Zardavas D, Piccart M. Neoadjuvant therapy for breast Cancer. Annu Rev Med. 2015;66(1):31\u201348.","journal-title":"Annu Rev Med"},{"issue":"4","key":"3537_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1015-9584(09)60048-8","volume":"27","author":"Y Xing","year":"2004","unstructured":"Xing Y, Cormier JN, Kuerer HM, Hunt KK. Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management. Asian J Surg. 2004;27(4):262\u20137.","journal-title":"Asian J Surg"},{"key":"3537_CR3","doi-asserted-by":"publisher","first-page":"1012646","DOI":"10.3389\/fonc.2022.1012646","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Pu S, Jiang S, Li D, Li S, Liu Y, et al. The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: a competing risk analysis using the SEER database. Front Oncol. 2022;12:1012646.","journal-title":"Front Oncol"},{"issue":"2","key":"3537_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.suc.2007.01.005","volume":"87","author":"AF Vitug","year":"2007","unstructured":"Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am. 2007;87(2):431\u2013. \u2013\u200951, x.","journal-title":"Surg Clin North Am"},{"issue":"10","key":"3537_CR5","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"8","key":"3537_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, et al. Tailoring therapies\u2013improving the management of early breast cancer: St Gallen International Expert Consensus on the primary therapy of early breast Cancer 2015. Ann Oncol. 2015;26(8):1533\u201346.","journal-title":"Ann Oncol"},{"issue":"2","key":"3537_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","volume":"173","author":"JM Classe","year":"2019","unstructured":"Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173(2):343\u201352.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"3537_CR8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jamasurg.2018.2696","volume":"153","author":"AU Barron","year":"2018","unstructured":"Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC. Association of Low nodal positivity rate among patients with ERBB2-Positive or triple-negative breast Cancer and breast pathologic complete response to Neoadjuvant Chemotherapy. JAMA Surg. 2018;153(12):1120\u20136.","journal-title":"JAMA Surg"},{"issue":"7","key":"3537_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609\u201318.","journal-title":"Lancet Oncol"},{"issue":"14","key":"3537_CR10","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361.","journal-title":"JAMA"},{"key":"3537_CR11","doi-asserted-by":"crossref","unstructured":"Curigliano G, Burstein HJ, E PW, Gnant M, Dubsky P, Loibl S, et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the primary therapy of early breast Cancer 2017. Ann Oncol. 2019;30(7):1181.","DOI":"10.1093\/annonc\/mdz235"},{"issue":"3","key":"3537_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426\u201332. discussion 32\u2009\u2013\u20093.","journal-title":"Ann Surg"},{"issue":"10","key":"3537_CR13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of Axillary Dissection vs no Axillary dissection on 10-Year overall survival among women with invasive breast Cancer and Sentinel Node Metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"13","key":"3537_CR14","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","volume":"390","author":"J de Boniface","year":"2024","unstructured":"de Boniface J, Filtenborg Tvedskov T, Ryd\u00e9n L, Szulkin R, Reimer T, K\u00fchn T, et al. Omitting Axillary dissection in breast Cancer with Sentinel-Node metastases. N Engl J Med. 2024;390(13):1163\u201375.","journal-title":"N Engl J Med"},{"issue":"12","key":"3537_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310.","journal-title":"Lancet Oncol"},{"issue":"6","key":"3537_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","volume":"21","author":"WJ Gradishar","year":"2023","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines\u00ae insights: breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023;21(6):594\u2013608.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"3537_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258\u201364.","journal-title":"J Clin Oncol"},{"issue":"27","key":"3537_CR18","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1200\/JCO.21.00934","volume":"39","author":"M Brackstone","year":"2021","unstructured":"Brackstone M, Baldassarre FG, Perera FE, Cil T, Chavez Mac Gregor M, Dayes IS, et al. Management of the Axilla in early-stage breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol. 2021;39(27):3056\u201382.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3537_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12885-016-2829-5","volume":"16","author":"Y Yu","year":"2016","unstructured":"Yu Y, Cui N, Li HY, Wu YM, Xu L, Fang M, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration. BMC Cancer. 2016;16(1):808.","journal-title":"BMC Cancer"},{"issue":"3","key":"3537_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jso.25989","volume":"122","author":"M Cheng","year":"2020","unstructured":"Cheng M, Zhuang X, Zhang L, Zhu T, Lin Y, Yang M, et al. A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN\u2009+\u2009breast cancer that downstages to cN0 after neoadjuvant chemotherapy. J Surg Oncol. 2020;122(3):373\u201381.","journal-title":"J Surg Oncol"},{"key":"3537_CR21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2147\/CMAR.S239921","volume":"12","author":"K Zhang","year":"2020","unstructured":"Zhang K, Zhu Q, Sheng D, Li J, Chang C. A New Model incorporating Axillary Ultrasound after Neoadjuvant Chemotherapy to Predict Non-sentinel Lymph Node Metastasis in invasive breast Cancer. Cancer Manag Res. 2020;12:965\u201372.","journal-title":"Cancer Manag Res"},{"key":"3537_CR22","doi-asserted-by":"crossref","unstructured":"Park M, Kim D, Ko S, Kim A, Mo K, Yoon H. Breast Cancer metastasis: mechanisms and therapeutic implications. Int J Mol Sci. 2022;23(12).","DOI":"10.3390\/ijms23126806"},{"issue":"3","key":"3537_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391\u20138. discussion 8-401.","journal-title":"Ann Surg"},{"issue":"8","key":"3537_CR24","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1245\/s10434-013-2932-7","volume":"20","author":"PJ Dings","year":"2013","unstructured":"Dings PJ, Elferink MA, Strobbe LJ, de Wilt JH. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study. Ann Surg Oncol. 2013;20(8):2607\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"3537_CR25","doi-asserted-by":"publisher","first-page":"29420","DOI":"10.18632\/oncotarget.8840","volume":"7","author":"J Zhou","year":"2016","unstructured":"Zhou J, Chen QH, Wu SG, He ZY, Sun JY, Li FY, et al. Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer. Oncotarget. 2016;7(20):29420\u20138.","journal-title":"Oncotarget"},{"issue":"2","key":"3537_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcms.2017.11.021","volume":"46","author":"M Zirk","year":"2018","unstructured":"Zirk M, Safi AF, Buller J, Nickenig HJ, Dreiseidler T, Zinser M, et al. Lymph node ratio as prognosticator in floor of mouth squamous cell carcinoma patients. J Craniomaxillofac Surg. 2018;46(2):195\u2013200.","journal-title":"J Craniomaxillofac Surg"},{"issue":"5","key":"3537_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/ejso.2002.1239","volume":"28","author":"BC van der Wal","year":"2002","unstructured":"van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28(5):481\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"18","key":"3537_CR28","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1200\/JCO.2005.03.1526","volume":"24","author":"WA Woodward","year":"2006","unstructured":"Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24(18):2910\u20136.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3537_CR29","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1200\/JCO.2008.18.6965","volume":"27","author":"V Vinh-Hung","year":"2009","unstructured":"Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27(7):1062\u20138.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3537_CR30","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1245\/s10434-011-2012-9","volume":"18","author":"AB Chagpar","year":"2011","unstructured":"Chagpar AB, Camp RL, Rimm DL. Lymph node ratio should be considered for incorporation into staging for breast cancer. Ann Surg Oncol. 2011;18(11):3143\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3537_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/RUQ.0000000000000495","volume":"36","author":"H Luo","year":"2020","unstructured":"Luo H, Mo Y, Zhong J, Zhang Y, Zhu L, Shi X, et al. Preoperative Axillary Ultrasound helps in the identification of a limited nodal burden in breast Cancer patients. Ultrasound Q. 2020;36(2):173\u20138.","journal-title":"Ultrasound Q"},{"issue":"1","key":"3537_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1148\/radiol.2018171987","volume":"288","author":"GR Kim","year":"2018","unstructured":"Kim GR, Choi JS, Han BK, Lee JE, Nam SJ, Ko EY, et al. Preoperative axillary US in early-stage breast Cancer: potential to prevent unnecessary Axillary Lymph Node Dissection. Radiology. 2018;288(1):55\u201363.","journal-title":"Radiology"},{"issue":"3","key":"3537_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2214\/AJR.07.2460","volume":"191","author":"DG Bedi","year":"2008","unstructured":"Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol. 2008;191(3):646\u201352.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"3537_CR34","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1148\/rg.2015140086","volume":"35","author":"B Pa\u00f1o","year":"2015","unstructured":"Pa\u00f1o B, Sebasti\u00e0 C, Ripoll E, Paredes P, Salvador R, Bu\u00f1esch L, et al. Pathways of lymphatic spread in gynecologic malignancies. Radiographics. 2015;35(3):916\u201345.","journal-title":"Radiographics"},{"issue":"2","key":"3537_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"11","key":"3537_CR36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.annonc.2021.08.1988","volume":"32","author":"S Schrodi","year":"2021","unstructured":"Schrodi S, Braun M, Andrulat A, Harbeck N, Mahner S, Kiechle M, et al. Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort. Ann Oncol. 2021;32(11):1410\u201324.","journal-title":"Ann Oncol"},{"issue":"7560","key":"3537_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature14583","volume":"523","author":"H Mohammed","year":"2015","unstructured":"Mohammed H, Russell IA, Stark R, Rueda OM, Hickey TE, Tarulli GA, et al. Progesterone receptor modulates ER\u03b1 action in breast cancer. Nature. 2015;523(7560):313\u20137.","journal-title":"Nature"},{"issue":"17","key":"3537_CR38","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1200\/JCO.19.02488","volume":"38","author":"P Tarantino","year":"2020","unstructured":"Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, et al. HER2-Low breast Cancer: pathological and clinical Landscape. J Clin Oncol. 2020;38(17):1951\u201362.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3537_CR39","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1245\/s10434-017-5898-z","volume":"24","author":"OA Petruolo","year":"2017","unstructured":"Petruolo OA, Pilewskie M, Patil S, Barrio AV, Stempel M, Wen HY, et al. Standard pathologic features can be used to identify a subset of Estrogen Receptor-Positive, HER2 negative patients likely to benefit from Neoadjuvant Chemotherapy. Ann Surg Oncol. 2017;24(9):2556\u201362.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3537_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12957-022-02492-7","volume":"20","author":"L Tang","year":"2022","unstructured":"Tang L, Shu X, Tu G. Exploring the influencing factors of the pathologic complete response in estrogen receptor-positive, HER2-negative breast cancer after neoadjuvant chemotherapy: a retrospective study. World J Surg Oncol. 2022;20(1):27.","journal-title":"World J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03537-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T10:04:00Z","timestamp":1727517840000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03537-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3537"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03537-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the local Ethics Committee of the Chongqing Medical University in view of the retrospective nature of the study and all the procedures being performed were part of the routine care. Written informed consent for publication was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}